Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, today announced that patients can now order the MyPhenome® genetic obesity test directly through ...
Some of the most challenging leakage-current-testing requirements are those for patient-monitoring devices—both invasive and noninvasive. Such testing can be time-consuming and expensive, so it is ...
For stable, symptomatic patients with suspected CAD who are deemed to be at “minimal risk” using a CT-based tool, deferral of diagnostic testing is just as safe as the usual approach and is even ...
The Chosun Ilbo on MSN
AI systems handle full patient care processes in trials
An artificial intelligence (AI) that asks patients about their symptoms, determines necessary tests, interprets results to ...
Mohana Ravindranath is a freelance health, science, and tech journalist and a 2025 Association for Health Care Journalists fellow. She was previously a Bay Area health tech correspondent for STAT.
OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions today announced U.S. Food and Drug Administration (FDA) ...
Computational point-of-care sensors can significantly improve access to diagnostics by enabling rapid patient testing outside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results